Assessment of Initial Oral Vinorelbine Dosing Schedules Used for the Treatment of Advanced Non-small-cell Lung Cancer and Metastatic Breast Cancer in Clinical Routine in Germany and Austria (StepUp)

Trial Profile

Assessment of Initial Oral Vinorelbine Dosing Schedules Used for the Treatment of Advanced Non-small-cell Lung Cancer and Metastatic Breast Cancer in Clinical Routine in Germany and Austria (StepUp)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs Vinorelbine (Primary)
  • Indications Advanced breast cancer; Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms StepUp
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 26 Sep 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
    • 26 Sep 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
    • 18 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top